Asian Pacific Journal of Cancer Prevention,14 (10), 5753-5759
GPX2 was the first selenoprotein identified as a target of the Wnt pathway, and its promoter contains five -catenin/TCF binding sites (TBE) (Li et al., 2020)
Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy
Its core pathological feature is excessive accumulation of adipose tissue, accompanied by abnormal proliferation, differentiation, and metabolic dysfunction of adipocytes, which in turn induce a series of complications including insulin resistance, nonalcoholic fatty liver disease, and cardiovascular diseases
Indications of the mechanisms involved in improved sperm parameters by zinc therapy